Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Gustave Roussy Meets His Audience
As part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur-Seine, Nogent-sur-Marne, Bry-sur-Marne, Le Kremlin-Bicêtre) from Monday through Saturday, 1:30 p.m. to 8:00 p.m.
Published on
This initiative is designed to raise awareness of the Institute’s missions, educate the public about the fight against cancer, and offer those who wish to do so the opportunity to support our work through regular donations.
The people who visit your home are acting on behalf of Gustave Roussy. They are specially trained to represent our organization, answer your questions, and inform you about our research, care, and innovation programs that benefit patients.
We understand that door-to-door outreach may raise questions. That is why we want to confirm that this campaign is officially authorized and overseen by the teams in Gustave Roussy’s Brand and Philanthropy Department.
Our “ambassadors” in the field:
- can be identified by a name badge and clothing bearing the Gustave Roussy logo (pink cap, pink sweatshirt, and burgundy vest);
- can present documents verifying their mission;
- never ask for cash or check donations during their visits;
- give everyone time to freely consider whether they wish to support our missions.
If you have any doubts about a visit, if you wish to verify an ambassador’s identity, or if you’d like to share a comment or feedback, we invite you to contact our Donor Relations department, available by phone Monday through Friday from 9 a.m. to 6 p.m. at 01 42 11 66 00 or by email at donsetlegs@gustaveroussy.fr, which is happy to assist you.
The trust of our donors and the general public is essential. We thank you for your trust and for your interest in Gustave Roussy’s mission to fight cancer.
Image edited and scene generated using artificial intelligence.
Last news
-
Mens November: Take care of your jewelry its precious!
November is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public awareness of these diseases—which account for approximately 63,000 new cases in France each year—and to encourage men to perform testicular self-exams, a simple step that can help detect a lump, the nature of which must then be determined through further medical examinations. Gustave Roussy has extensive expertise in the treatment of male cancers, particularly through its Genitourinary Oncology Committee, which is deeply involved in research on these diseases.
-
Nuclear medicine: DART, a pioneering platform for the development of alpha therapy
Developed through a partnership between Gustave Roussy and the Paris-Saclay Cancer Cluster, the DART project aims to provide industry partners with a centre of excellence spanning preclinical, clinical and translational research to support the development of alpha therapy. This innovative nuclear medicine approach can destroy cancer cells more powerfully than standard approaches while reducing damage to surrounding healthy cells.
-
Gustave Roussy at the ESMO 2026 Congress
The European Society for Medical Oncology (ESMO) is holding its annual congress from 23 to 27 October in Madrid, Spain. This major international event provides oncologists and researchers from around the world with an opportunity to present the latest findings from clinical studies aimed at improving cancer care and deepening our understanding of the disease. Once again, this year, physicians and researchers from Gustave Roussy have contributed to several dozen studies that will be presented during the five-day congress.
-
5 questions with Dr François-Xavier Danlos about therapeutic cancer vaccines
Therapeutic cancer vaccines are making significant progress in clinical development. The ESMO Congress, which begins on 23 October, will provide an opportunity to learn about new data on a therapeutic vaccine against melanoma. However, there are major differences between vaccines traditionally used to prevent disease and therapeutic cancer vaccines. Dr François-Xavier Danlos, a medical oncologist in Gustave Roussy’s Drug Development Department and a specialist in immunotherapy development, explains.
